United States· US:0006-3025_12338d29-efb0-4943-b5f5-826350e9ec46
ZINPLAVA
A bezlotoxumab product containing bezlotoxumab, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 9 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bezlotoxumab is registered in 9 of 19 countries.
Countries holding a registration under ATC J06BC03 (bezlotoxumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Bezlotoxumab · ATC J06BC03
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BEZLOTOXUMAB
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- J06BC03
- ATC class
- Bezlotoxumab
- Defined daily dose
- 0.7 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100063025001 VIAL, SINGLE-DOSE in 1 CARTON (0006-3025-00) / 40 mL in 1 VIAL, SINGLE-DOSE (0006-3025-01)
- ndc110006-3025-00
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bezlotoxumab in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainZINPLAVA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- BelgiumZinplava 25 mg/mlMerck Sharp & Dohme
- CzechiaZINPLAVAMerck Sharp & Dohme B.V., Haarlem
- FinlandZINPLAVAMerck Sharp & Dohme B.V.
- FranceZINPLAVA 25 mg/mL, solution à diluer pour perfusionMERCK SHARP & DOHME (PAYS-BAS)
- United KingdomZinplava 1g/40ml concentrate for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- IrelandZINPLAVA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme BV
- IcelandZinplavaMerck Sharp & Dohme B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zinplava
- Liechtenstein · Zinplava
- Norway · Zinplava
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8358030f-1d6f-4e70-a4fb-6341741fac8f GET /v1/drugs/8358030f-1d6f-4e70-a4fb-6341741fac8f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "25",
"substance": "BEZLOTOXUMAB",
"productndc": "0006-3025",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761046",
"marketing_category": "BLA"
}See everything about bezlotoxumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.